title: Intracavitary Bacillus Calmette-Guerin in the Treatment of Superficial Bladder Tumors.
abstract: Patients with recurrent superficial bladder tumors have been treated by vesical and intradermal administration of Bacillus Calmette-Guerin. The pattern of recurrence in 9 patients has been altered favorably. Although the findings are still preliminary they appear to hold promise of a new therapeutic approach to the treatment of a group of neoplasms for which effective therapy is still lacking.
authors.affiliation: Departments of Urology, and Microbiology and Immunology, Queen's University, Kingston, Ontario, Canada.
authors.forename: A
authors.initials: A
authors.lastname: Morales
authors.affiliation: Departments of Urology, and Microbiology and Immunology, Queen's University, Kingston, Ontario, Canada.
authors.forename: D
authors.initials: D
authors.lastname: Eidinger
authors.affiliation: Departments of Urology, and Microbiology and Immunology, Queen's University, Kingston, Ontario, Canada.
authors.forename: A W
authors.initials: AW
authors.lastname: Bruce
mesh_terms: D000283:Administration, Intravesical; D000368:Aged; D000369:Aged, 80 and over; D000074322:Antineoplastic Agents, Immunological / Q000008:administration & dosage*; D001500:BCG Vaccine / Q000008:administration & dosage*; D002295:Carcinoma, Transitional Cell / Q000276:immunology / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D003558:Cystoscopy; D005260:Female; D006801:Humans; D007271:Injections, Intradermal; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D012189:Retrospective Studies; D001749:Urinary Bladder Neoplasms / Q000276:immunology / Q000473:pathology / Q000601:surgery / Q000628:therapy*
chemical_list: D000074322:Antineoplastic Agents, Immunological; D001500:BCG Vaccine